Undifferentiated uterine sarcoma: case report

Authors

  • María F. Zalapa Tecnológico de Monterrey, School of Medicine and Health Sciences at Tec Salud, Monterrey, Nuevo León, México
  • Patricio Mendoza Tecnológico de Monterrey, School of Medicine and Health Sciences at Tec Salud, Monterrey, Nuevo León, México
  • Victoria P. Holguín Tecnológico de Monterrey, School of Medicine and Health Sciences at Tec Salud, Monterrey, Nuevo León, México https://orcid.org/0000-0001-6641-2508
  • Raúl Leal-González Department of Obstetrics and Gynecology, Tecnológico de Monterrey, School of Medicine and Health Sciences at Tec Salud, Monterrey, Nuevo León, México

DOI:

https://doi.org/10.18203/2320-6012.ijrms20230188

Keywords:

Uterine sarcoma, Endometrial sarcoma, Mesodermal tumors, Case report

Abstract

Undifferentiated uterine sarcoma is a rare condition characterized by abnormal bleeding and pelvic pain, which may overlap with the clinical picture of uterine myomatosis. Its presentation is usually chronic and drastically affects the stage at the time of diagnosis. Since it is usually seen in postmenopausal patients, undifferentiated uterine sarcoma presentation in premenopausal patients is rare. We herein report a rare presentation of undifferentiated uterine sarcoma in a 58-year-old Mexican woman, who suffered from progressive pelvic pain for 3 months as well as a 5-day course of postmenopausal bleeding. Study images revealed a pedunculated uterine-mass suggestive of sarcomatous degeneration, accompanied by a left internal iliac necrotic adenopathy, as well as scarce pelvic free fluid. The patient underwent a pelvic tumor and implants resection, total abdominal hysterectomy, bilateral salpingo-oophorectomy, pelvic lymphadenectomy, omentectomy and appendectomy via laparotomy. Despite the therapeutic options for the management of undifferentiated uterine sarcomas described in literature, its survival rate varies between 21% to 68%, when diagnosed on time and depending on if the cancer is localized, regional or distant.

Metrics

Metrics Loading ...

References

American Cancer Society. Uterine Sarcoma Survival Rates. American Cancer Society. 2022. Available at: https://www.cancer.org/cancer/uterine-sarcoma/ detection-diagnosis-staging/survival-rates.html. Accessed on 24 November 2022.

Cotzia P, Benayed R, Mullaney K, Oliva E, Felix A, Ferreira J, Soslow RA, Antonescu CR, Ladanyi M, Chiang S. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas. Am J Surg Pathol. 2019;43(5):662-9.

Denschlag D, Ulrich UA. Uterine Carcinosarcomas - Diagnosis and Management. Oncol Res Treat. 2018;41(11):675-9.

Fernandez G, Borràs SM, Pérez VN, Guedea F. Treatment of pure uterine sarcoma at the Institut Català D'Oncologia. Rep Pract Oncol Radiother. 2013;18(3):153-8.

Kurihara S, Oda Y, Ohishi Y, Iwasa A, Takahira T, Kaneki E, Kobayashi H, Wake N, Tsuneyoshi M. Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases. Am J Surg Pathol. 2008;32(8):1228-38.

Martínez-Madrigal MM, Muñoz-González D, Ochoa-Carrillo J, Camacho-Beiza I, García-Juárez E, Flores-Manzur M. Sarcoma uterino, Revisión de la literatura. Gaceta Mexicana de Oncología. 2012;11:113-7.

Reed NS, Mangioni C, Malmström H, Scarfone G, Poveda A, Pecorelli S, et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer. 2008;44(6):808-18.

Downloads

Published

2023-01-25

How to Cite

Zalapa, M. F., Mendoza, P., Holguín, V. P., & Leal-González, R. (2023). Undifferentiated uterine sarcoma: case report. International Journal of Research in Medical Sciences, 11(2), 697–700. https://doi.org/10.18203/2320-6012.ijrms20230188

Issue

Section

Case Reports